Caljouw Lynne J 4

4 · Sensata Technologies Holding plc · Filed Jun 4, 2021

Form 4

Period: 2021-06-02

EVP, Chief HR Officer

Transactions

Sale
Ordinary Shares, par value EUR 0.01 per share
2021-06-02$59.49/sh−5,490$326,622→ 30,199 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.01 per share
2021-06-02$38.96/sh+2,124$82,751→ 32,323 total
Exercise/Conversion
Stock options to Buy
2021-06-02−2,124→ 0 total
Exercise: $38.96Exp: 2026-04-01→ Ordinary Shares, par value EUR 0.01 per share (2,124 underlying)
Exercise/Conversion
Stock options to Buy
2021-06-02−2,467→ 823 total
Exercise: $51.83Exp: 2028-04-01→ Ordinary Shares, par value EUR 0.01 per share (2,467 underlying)
Exercise/Conversion
Ordinary Shares, par value EUR 0.01 per share
2021-06-02$43.67/sh+899$39,259→ 33,222 total
Exercise/Conversion
Ordinary Shares, par value EUR 0.01 per share
2021-06-02$51.83/sh+2,467$127,865→ 35,689 total
Sale
Ordinary Shares, par value EUR 0.01 per share
2021-06-02$59.44/sh−977$58,072→ 29,222 total
Exercise/Conversion
Stock options to Buy
2021-06-02−899→ 3,226 total
Exercise: $43.67Exp: 2027-04-01→ Ordinary Shares, par value EUR 0.01 per share (899 underlying)

Footnotes (6)

[F1]Includes 28,245 unvested restricted stock units, of which 14,956 are subject to performance conditions.
[F2]Reflects the sale of an aggregate of 5,490 shares of common stock on June 2, 2021, at the weighted average sales price of $59.4940. The prices for these sales range from $59.28 to $60.00. The filer undertakes to provide, upon request by the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F3]Reflects the sale of an aggregate of 977 shares of common stock on June 2, 2021, at the weighted average sales price of $59.4388. The prices for these sales range from $59.28 to $59.51. The filer undertakes to provide, upon request by the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F4]This option grant became exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2017. All options are currently exercisable.
[F5]This option grant became exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2018. All options are currently exercisable.
[F6]This option grant becomes exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2019. Prior to this transacation, 2,467 options were exercisable.

Documents

1 file